Search results
Dilip Shanghvi (born 1 October 1955) is an Indian billionaire businessman. As the founder of Sun Pharmaceuticals, he is one of the country's richest people. [2] [3] The Government of India awarded him the civilian honor of the Padma Shri in 2016. [4] India Today magazine ranked him 8th in India's most powerful people of 2017 list. [5]
Sep 27, 2024 · The son of a pharmaceuticals distributor, Dilip Shanghvi borrowed $200 from his father to start Sun Pharmaceutical Industries in 1983 to make psychiatric...
Dilip Shanghvi, Young Entrepreneur Who Became India’s Richest Man. The man who once beat Mukesh Ambani in the list of richest people in India, Dilip Shanghvi is the owner of India's biggest pharmaceutical company, Sun Pharma.
Dilip Shanghvi is the Founder Chairman and Managing Director of Sun Pharmaceutical Industries Limited. He is also the Chairman of Sun Pharma Advanced Research Company Ltd., which is engaged in R&D of new innovative drugs and delivery technologies.
Jun 12, 2024 · In the dynamic landscape of Indian business, few names evoke as much admiration and respect as Dilip Shanghvi. As the founder of Sun Pharmaceuticals, he stands as a towering figure, not only in the pharmaceutical industry but also in the broader spectrum of Indian entrepreneurship.
Dilip Shanghvi, Indian business executive who was the founder (1983) of Sun Pharmaceutical Industries Ltd., which became the largest pharmaceutical company in India and one of the largest generic-drug producers in the world. Learn more about Shanghvi’s life and career.
Dilip Shanghvi is the founder of Sun Pharmaceuticals has extensive industrial experience in the pharmaceutical industry.
Son of a pharma distributor, Dilip Shanghvi borrowed $200 from his father to start Sun Pharmaceutical Industries in 1983 to make psychiatric drugs. The company...
Sep 12, 2022 · Among the most low-profile pharma leaders in India, Dilip Shanghvi has had a terrific run. One of his major milestones being the 2014 acquisition of Ranbaxy for $4 billion from Japan's Daiichi Sankyo, that catapulted Sun Pharma to the world's fifth-largest specialty generics major.
5 days ago · Overview. Shanghvi is the founder of Sun Pharmaceutical Industries, a generic drugmaker with revenue of $5.4 billion in the year to March 31, 2023. The Mumbai-based company has more than 40...
